DOTA-XYIMSR-01, CAS [[2051527-54-7]] Preis auf Anfrage

Produktübersicht

• Artikelname: DOTA-XYIMSR-01, CAS [[2051527-54-7]] Preis auf Anfrage
• Artikelnummer: TGM-T206524
• Hersteller Artikelnummer: T206524
• Alternativnummer: TGM-T206524-10MG,TGM-T206524-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

DOTA-XYIMSR-01 is a molecular probe targeting CAIX, capable of being labeled with 177Lu for the treatment and localization of malignant gliomas. The uptake of [177Lu]Lu-XYIMSR-01 in U87MG tumors is 6.19% injected dose per gram (% ID/g), with a tumor-to-muscle uptake ratio of 20.14. In an orthotopic glioma model, co-administration with temozolomide significantly enhances survival rates and inhibits tumor growth in mice. DOTA-XYIMSR-01 shows potential for research in the field of cancer treatment.

Produkteigenschaften

• Molekulargewicht: 1461.57
• CAS Nummer: [2051527-54-7]
• Formel: C61H88N16O22S2
• Target-Kategorie: Carbonic Anhydrase

Bilder

T206524